Have you ever wanted an insider peek into the FDA? Join the HBA Women in Science affinity group for a reception on Monday, 5 November featuring Dr. Kathleen Uhl, director of generic drugs. She will talk about her experience at the FDA, including the culture and her career journey. There will be time for Q&A and networking. We look forward to an educational, interactive reception.
7:30 - 7:40 PM – Arrival and networking
7:40 - 7:45 PM – Introduction
7:45 - 8:15 PM – Dr. Uhl’s remarks
8:15 - 8:45 PM – Q&A and networking
About Kathleen Uhl, MD
Kathleen Uhl, MDKathleen Uhl, MD currently serves as the Director for the Office of Generic Drugs in the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration (FDA). This office is responsible for the review and approval of Abbreviated New Drug Applications (ANDAs) and is largely tasked with implementing the Generic Drug User Fee Amendments (GDUFA).
Dr. Uhl began her career with FDA in 1998 as a medical officer in the Office of Clinical Pharmacology and has served in numerous positions at FDA, including the assistant commissioner for women’s health and the director of FDA’s Office of Women’s Health and the deputy director of the Office of Medical Policy in CDER. She received her undergraduate degree from Temple University and her medical degree from the Medical College of Pennsylvania, with subsequent fellowship training in medical research and clinical pharmacology at the Uniformed Services University in Bethesda, MD. She retains faculty appointments as adjunct professor in family medicine and internal medicine at the Uniformed Services University. She has served as an officer in the US Army and is a retired officer of the US Public Health Service Commissioned Corps.